DJIA 16,880.36 0.00 0.00%
NASDAQ 4,462.90 0.00 0.00%
S&P 500 1,970.07 0.00 0.00%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

Why Vertex Pharmaceuticals (VRTX) Stock Hit a One-Year High Today

Vertex Rockets On Drug Combo Success

Vertex soars on trial success; Walgreen falls

Vertex Pharmaceuticals (VRTX) Off To A Strong Start In Pre-Market Activity

Nasdaq 100 Movers: NVDA, TSLA

Dow 30 Stock Roundup: Intel Ups Q2 Guidance, Boeing Set to Win China Eastern's $7.4B Order - Analyst

Dow 30 Stock Roundup: Intel Ups Q2 Guidance, Boeing Set to Win China Eastern's $7.4B Order - Analyst Blog

The Wild Ride That Is the Vertex Trial Show: How to Play It

The outcome of a Vertex drug trial for cystic fibrosis treatment could have a drastic impact on share price; JPM says the stock could eventually trade anywhere between $32 and $134 per share.

Vertex Pharmaceuticals-Johnson & Johnson Collaborate on Flu Drug - Analyst Blog

3 Stocks Pulling The Drugs Industry Downward

Vertex Pharmaceuticals Crumbles on Analyst Worries - Analyst Blog

See More Articles...